These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 23690408

  • 1. International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.
    Terpos E, Morgan G, Dimopoulos MA, Drake MT, Lentzsch S, Raje N, Sezer O, García-Sanz R, Shimizu K, Turesson I, Reiman T, Jurczyszyn A, Merlini G, Spencer A, Leleu X, Cavo M, Munshi N, Rajkumar SV, Durie BG, Roodman GD.
    J Clin Oncol; 2013 Jun 20; 31(18):2347-57. PubMed ID: 23690408
    [Abstract] [Full Text] [Related]

  • 2. Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial.
    Morgan GJ, Child JA, Gregory WM, Szubert AJ, Cocks K, Bell SE, Navarro-Coy N, Drayson MT, Owen RG, Feyler S, Ashcroft AJ, Ross FM, Byrne J, Roddie H, Rudin C, Cook G, Jackson GH, Wu P, Davies FE, National Cancer Research Institute Haematological Oncology Clinical Studies Group.
    Lancet Oncol; 2011 Aug 20; 12(8):743-52. PubMed ID: 21771568
    [Abstract] [Full Text] [Related]

  • 3. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.
    Morgan GJ, Davies FE, Gregory WM, Cocks K, Bell SE, Szubert AJ, Navarro-Coy N, Drayson MT, Owen RG, Feyler S, Ashcroft AJ, Ross F, Byrne J, Roddie H, Rudin C, Cook G, Jackson GH, Child JA, National Cancer Research Institute Haematological Oncology Clinical Study Group.
    Lancet; 2010 Dec 11; 376(9757):1989-99. PubMed ID: 21131037
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R, Redzepovic J, Wheatley K, Clark OA, Miladinovic B, Glasmacher A, Kumar A, Djulbegovic B.
    Cochrane Database Syst Rev; 2012 May 16; (5):CD003188. PubMed ID: 22592688
    [Abstract] [Full Text] [Related]

  • 6. Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.
    Morgan GJ, Davies FE, Gregory WM, Szubert AJ, Bell SE, Drayson MT, Owen RG, Ashcroft AJ, Jackson GH, Child JA, National Cancer Research Institute Haematological Oncology Clinical Studies Group.
    Blood; 2012 Jun 07; 119(23):5374-83. PubMed ID: 22498739
    [Abstract] [Full Text] [Related]

  • 7. Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.
    Jackson GH, Morgan GJ, Davies FE, Wu P, Gregory WM, Bell SE, Szubert AJ, Navarro Coy N, Drayson MT, Owen RG, Feyler S, Ashcroft AJ, Ross FM, Byrne J, Roddie H, Rudin C, Boyd KD, Osborne WL, Cook G, Child JA.
    Br J Haematol; 2014 Jul 07; 166(1):109-17. PubMed ID: 24673708
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.
    Berenson JR, Hillner BE, Kyle RA, Anderson K, Lipton A, Yee GC, Biermann JS, American Society of Clinical Oncology Bisphosphonates Expert Panel.
    J Clin Oncol; 2002 Sep 01; 20(17):3719-36. PubMed ID: 12202673
    [Abstract] [Full Text] [Related]

  • 10. Bisphosphonate therapy in multiple myeloma: past, present, future.
    Jantunen E.
    Eur J Haematol; 2002 Sep 01; 69(5-6):257-64. PubMed ID: 12460229
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bisphosphonates in multiple myeloma.
    Berenson JR.
    Cancer; 1997 Oct 15; 80(8 Suppl):1661-7. PubMed ID: 9362433
    [Abstract] [Full Text] [Related]

  • 14. Can bisphosphonates improve outcomes in patients with newly diagnosed multiple myeloma?
    Morgan GJ.
    Crit Rev Oncol Hematol; 2011 Feb 15; 77 Suppl 1():S24-30. PubMed ID: 21353177
    [Abstract] [Full Text] [Related]

  • 15. Management of bone disease in multiple myeloma.
    Terpos E, Berenson J, Raje N, Roodman GD.
    Expert Rev Hematol; 2014 Feb 15; 7(1):113-25. PubMed ID: 24433088
    [Abstract] [Full Text] [Related]

  • 16. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: definition and management of the risk related to zoledronic acid.
    Cafro AM, Barbarano L, Nosari AM, D'Avanzo G, Nichelatti M, Bibas M, Gaglioti D, Taroni A, Riva F, Morra E, Andriani A.
    Clin Lymphoma Myeloma; 2008 Apr 15; 8(2):111-6. PubMed ID: 18501105
    [Abstract] [Full Text] [Related]

  • 17. Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group.
    Terpos E, Zamagni E, Lentzsch S, Drake MT, García-Sanz R, Abildgaard N, Ntanasis-Stathopoulos I, Schjesvold F, de la Rubia J, Kyriakou C, Hillengass J, Zweegman S, Cavo M, Moreau P, San-Miguel J, Dimopoulos MA, Munshi N, Durie BGM, Raje N, Bone Working Group of the International Myeloma Working Group.
    Lancet Oncol; 2021 Mar 15; 22(3):e119-e130. PubMed ID: 33545067
    [Abstract] [Full Text] [Related]

  • 18. The Medical Research Council Myeloma IX trial: the impact on treatment paradigms.
    Richardson PG, Laubach JP, Schlossman RL, Ghobrial IM, Mitsiades CS, Rosenblatt J, Mahindra A, Raje N, Munshi N, Anderson KC.
    Eur J Haematol; 2012 Jan 15; 88(1):1-7. PubMed ID: 21991938
    [Abstract] [Full Text] [Related]

  • 19. The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.
    Terpos E, Sezer O, Croucher PI, García-Sanz R, Boccadoro M, San Miguel J, Ashcroft J, Bladé J, Cavo M, Delforge M, Dimopoulos MA, Facon T, Macro M, Waage A, Sonneveld P, European Myeloma Network.
    Ann Oncol; 2009 Aug 15; 20(8):1303-17. PubMed ID: 19465418
    [Abstract] [Full Text] [Related]

  • 20. Advances in imaging and the management of myeloma bone disease.
    Terpos E, Moulopoulos LA, Dimopoulos MA.
    J Clin Oncol; 2011 May 10; 29(14):1907-15. PubMed ID: 21483016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.